27.2 Million People of All Ages Uninsured in 2024 in the United States
By Elana Gotkine HealthDay Reporter
Medically reviewed by Drugs.com

FRIDAY, June 27, 2025 -- A total of 27.2 million people of all ages were uninsured in 2024, marking a nonsignificant increase from 25.0 million in 2023, according to early estimates from the National Health Interview Survey, 2024, released by the National Center for Health Statistics.
Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues calculated health insurance coverage estimates for 2024 using data from the National Health Interview Survey; they also examined selected trends from 2020 to 2024.
The researchers found that 27.2 million people of all ages (8.2 percent) were uninsured at the time of the interview in 2024. This was higher than 2023, when 25.0 million people of all ages (7.6 percent) were uninsured, but the difference was not statistically significant. In 2024, 11.6 percent of adults aged 18 to 64 years were uninsured at the time of interview, while 21.2 and 69.1 percent had public and private health insurance coverage, respectively. Compared with 2023, the percentage of adults aged 18 to 64 years with public coverage was lower in 2024 (21.2 versus 23.0 percent). Among children aged 0 to 17 years, 5.1, 41.6, and 55.4 percent were uninsured, had public coverage, and had private coverage, respectively.
There was an increase seen in the percentage of people younger than age 65 years with exchange-based coverage, from 3.8 percent in 2020 to 5.7 percent in 2024.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-28 12:00
Read more

- Fecal Transplant Potential First-Line Treatment For C. Difficile Infection
- FDA Approves Yeztugo (lenacapavir) as the First and Only HIV Prevention Option Offering 6 Months of Protection
- Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years
- Trump Administration To End Lifeline for LGBTQ+ Youth This July
- Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug
- Close to 150,000 Pounds of Ready-to-eat Bologna Recalled Due to Mislabeling
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions